InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64
United States Fiscal year ends December CIK 0001655759
$7.64 +1.73% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.64 −90.65% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 27 Sep 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue7.6Operating income−24.8Net income−24.0Fiscal year 2018Revenue14.3 +88.7%Operating income−43.8Net income−41.5Fiscal year 2019Revenue18.3 +28.0%Operating income−51.5Net income−70.3EPS, diluted−2.13Fiscal year 2020Revenue21.8 +19.1%Operating income−120.8Net income−119.3EPS, diluted−3.02Fiscal year 2021Revenue46.7 +114.2%Operating income−188.4Net income−191.0EPS, diluted−3.82Fiscal year 2022Revenue131.4 +181.4%Operating income−263.2Net income−282.5EPS, diluted−5.31Fiscal year 2023Revenue78.5 −40.3%Operating income−401.5Net income−367.3EPS, diluted−6.62Fiscal year 2024Revenue263.4 +235.5%Operating income−250.2Net income−198.9EPS, diluted−2.77Fiscal year 2025Revenue262.6 −0.3%Operating income−118.5Net income−80.8EPS, diluted−1.14
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 7.6 14.3 18.3 21.8 46.7 131.4 78.5 263.4 262.6
Growth +88.7% +28.0% +19.1% +114.2% +181.4% −40.3% +235.5% −0.3%
Operating income −24.8 −43.8 −51.5 −120.8 −188.4 −263.2 −401.5 −250.2 −118.5
Net income −24.0 −41.5 −70.3 −119.3 −191.0 −282.5 −367.3 −198.9 −80.8
Growth
EPS, diluted n/a n/a −2.13 −3.02 −3.82 −5.31 −6.62 −2.77 −1.14
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−326.7%Net margin−317.3%Free cash flow margin54.1%Fiscal year 2018Operating margin−306.3%Net margin−290.1%Free cash flow margin−132.5%Fiscal year 2019Operating margin−281.4%Net margin−384.2%Free cash flow margin−256.3%Fiscal year 2020Operating margin−554.1%Net margin−547.2%Free cash flow margin−440.8%Fiscal year 2021Operating margin−403.4%Net margin−409.0%Free cash flow margin1,187.8%Fiscal year 2022Operating margin−200.3%Net margin−215.0%Free cash flow margin−213.3%Fiscal year 2023Operating margin−511.5%Net margin−467.9%Free cash flow margin−446.8%Fiscal year 2024Operating margin−95.0%Net margin−75.5%Free cash flow margin−99.1%Fiscal year 2025Operating margin−45.1%Net margin−30.8%Free cash flow margin−105.0%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −326.7% −306.3% −281.4% −554.1% −403.4% −200.3% −511.5% −95.0% −45.1%
Net margin −317.3% −290.1% −384.2% −547.2% −409.0% −215.0% −467.9% −75.5% −30.8%
Free cash flow margin 54.1% −132.5% −256.3% −440.8% 1,187.8% −213.3% −446.8% −99.1% −105.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow5.1Capital expenditure−1.0Free cash flow4.1Fiscal year 2018Operating cash flow−16.1Capital expenditure−2.8Free cash flow−18.9 −562.1%Fiscal year 2019Operating cash flow−40.6Capital expenditure−6.3Free cash flow−46.9Fiscal year 2020Operating cash flow−89.7Capital expenditure−6.4Free cash flow−96.1Fiscal year 2021Operating cash flow559.4Capital expenditure−4.7Free cash flow554.7Fiscal year 2022Operating cash flow−273.5Capital expenditure−6.8Free cash flow−280.3 −150.5%Fiscal year 2023Operating cash flow−347.8Capital expenditure−2.9Free cash flow−350.7Buybacks0.0Fiscal year 2024Operating cash flow−259.3Capital expenditure−1.8Free cash flow−261.1Buybacks0.0Fiscal year 2025Operating cash flow−273.8Capital expenditure−1.9Free cash flow−275.7Buybacks−91.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 5.1 −16.1 −40.6 −89.7 559.4 −273.5 −347.8 −259.3 −273.8
Capital expenditure −1.0 −2.8 −6.3 −6.4 −4.7 −6.8 −2.9 −1.8 −1.9
Free cash flow 4.1 −18.9 −46.9 −96.1 554.7 −280.3 −350.7 −261.1 −275.7
Growth −562.1% −150.5%
Buybacks n/a n/a n/a n/a n/a n/a 0.0 0.0 −91.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash30.9Total debt0.3Net cash (debt)30.6Shareholders’ equity−61.2Fiscal year 2018Cash3.2Total debt2.2Net cash (debt)1.0Shareholders’ equity136.6Debt to equity0.02Fiscal year 2019Cash9.2Total debt2.0Net cash (debt)7.2Shareholders’ equity226.6Debt to equity0.01Fiscal year 2020Cash588.4Total debt2.0Net cash (debt)586.4Shareholders’ equity642.2Debt to equity0.00Fiscal year 2021Cash108.3Total debt1.0Net cash (debt)107.3Shareholders’ equity781.7Debt to equity0.00Fiscal year 2022Cash81.3Total debt1.0Net cash (debt)80.3Shareholders’ equity564.9Debt to equity0.00Fiscal year 2023Cash311.7Total debt1.0Net cash (debt)310.7Shareholders’ equity660.0Debt to equity0.00Fiscal year 2024Cash100.5Total debt0.8Net cash (debt)99.7Shareholders’ equity561.7Debt to equity0.00Fiscal year 2025Cash142.9Total debt0.6Net cash (debt)142.3Shareholders’ equity433.9Debt to equity0.00
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 30.9 3.2 9.2 588.4 108.3 81.3 311.7 100.5 142.9
Total debt 0.3 2.2 2.0 2.0 1.0 1.0 1.0 0.8 0.6
Net cash (debt) 30.6 1.0 7.2 586.4 107.3 80.3 310.7 99.7 142.3
Shareholders’ equity −61.2 136.6 226.6 642.2 781.7 564.9 660.0 561.7 433.9
Debt to equity n/a 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
7.6 14.3 18.3 21.8 46.7 131.4 78.5 263.4 262.6
Growth +88.7% +28.0% +19.1% +114.2% +181.4% −40.3% +235.5% −0.3%
28.8 45.2 67.2 108.4 180.4 315.0 379.7 348.2 285.2
3.5 12.9 27.3 38.3 61.6 79.6 100.3 165.4 95.9
−24.8 −43.8 −51.5 −120.8 −188.4 −263.2 −401.5 −250.2 −118.5
Growth
n/a n/a n/a −115.2 −184.1 −251.0 −363.9 −198.3 −80.5
0.0 0.0 0.0 0.0 0.0 20.9 0.9 0.6 0.3
−24.0 −41.5 −70.3 −119.3 −191.0 −282.5 −367.3 −198.9 −80.8
Growth
Per share
n/a n/a −2.13 −3.02 −3.82 −5.31 −6.62 −2.77 −1.14
n/a n/a −2.13 −3.02 −3.82 −5.31 −6.62 −2.77 −1.14
Growth
n/a n/a 32.9 39.5 50.0 53.2 55.5 71.9 70.9
n/a n/a 32.9 39.5 50.0 53.2 55.5 71.9 70.9
Growth +20.1% +26.6% +6.4% +4.3% +29.5% −1.4%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 64.5% a year over five years.
  • The diluted share count rose 79.5% in five years, which is dilution.
  • Operating margin is up 509.0 points on five years ago, at -45.1%.
  • A net loss in 9 of 9 years on file.